Electrical Stimulation Therapies Promote Spinal Fusion
|
By HospiMedica International staff writers Posted on 15 Oct 2019 |
A new study suggests that electrical stimulation devices may produce clinically significant increases in arthrodesis rates among patients undergoing spinal fusion.
Researchers at Johns Hopkins University School of Medicine (JHU-SOM; Baltimore, MD, USA) conducted a systematic review of PubMed, Embase, and the Web of Science databases to study the effect of electrical stimulation technologies--including direct current stimulation (DCS), capacitive coupling stimulation (CCS), and inductive coupling stimulation (ICS)--on bone union following spinal fusion. In all, 11 preclinical studies and 13 clinical studies involving 2,144 patients were included in the meta-analysis. The primary endpoint was fusion rate at last follow-up.
The results revealed that among the preclinical studies, mean fusion rates were higher among electrical stimulation treated animals. The human clinical studies similarly showed that electrical stimulation increased fusion rates. But of the various modalities tested, only DCS improved fusion rates in both preclinical and clinical populations, while ICS improved fusion only in clinical studies. CCS was not found to be effective at increasing fusion. A subsequent sub-analysis showed increased fusion rates in patients with difficult-to-fuse spines, smokers, and multilevel fusions. The study was published on October 8, 2019, in the Journal of Neurosurgery: Spine.
“We were surprised by how large an effect these therapies have on spinal fusion,” said senior author Daniel Sciubba, MD, of the JHU-SOM department of neurosurgery. “It was also encouraging to see that the preclinical data aligned with the clinical evidence, which supports future translational research efforts in spine surgery. Ultimately, we hope our findings will help to inform patients and providers to enhance outcomes following spinal fusion.”
DCS requires implantation of a stimulation device, usually done at the time of spinal fusion surgery. Via electrodes, the battery-powered device delivers a small direct current of electricity to the area where fusion needs to occur. CCS is noninvasive; the external device uses two small electrode pads placed on the skin over the region of desired bone fusion, which produce an electrical field surrounding the region when powered by an external alternating current generator. ICS involves the use of coils placed on the skin to produce an electromagnetic field to induce bone fusion.
Related Links:
Johns Hopkins University School of Medicine
Researchers at Johns Hopkins University School of Medicine (JHU-SOM; Baltimore, MD, USA) conducted a systematic review of PubMed, Embase, and the Web of Science databases to study the effect of electrical stimulation technologies--including direct current stimulation (DCS), capacitive coupling stimulation (CCS), and inductive coupling stimulation (ICS)--on bone union following spinal fusion. In all, 11 preclinical studies and 13 clinical studies involving 2,144 patients were included in the meta-analysis. The primary endpoint was fusion rate at last follow-up.
The results revealed that among the preclinical studies, mean fusion rates were higher among electrical stimulation treated animals. The human clinical studies similarly showed that electrical stimulation increased fusion rates. But of the various modalities tested, only DCS improved fusion rates in both preclinical and clinical populations, while ICS improved fusion only in clinical studies. CCS was not found to be effective at increasing fusion. A subsequent sub-analysis showed increased fusion rates in patients with difficult-to-fuse spines, smokers, and multilevel fusions. The study was published on October 8, 2019, in the Journal of Neurosurgery: Spine.
“We were surprised by how large an effect these therapies have on spinal fusion,” said senior author Daniel Sciubba, MD, of the JHU-SOM department of neurosurgery. “It was also encouraging to see that the preclinical data aligned with the clinical evidence, which supports future translational research efforts in spine surgery. Ultimately, we hope our findings will help to inform patients and providers to enhance outcomes following spinal fusion.”
DCS requires implantation of a stimulation device, usually done at the time of spinal fusion surgery. Via electrodes, the battery-powered device delivers a small direct current of electricity to the area where fusion needs to occur. CCS is noninvasive; the external device uses two small electrode pads placed on the skin over the region of desired bone fusion, which produce an electrical field surrounding the region when powered by an external alternating current generator. ICS involves the use of coils placed on the skin to produce an electromagnetic field to induce bone fusion.
Related Links:
Johns Hopkins University School of Medicine
Latest Surgical Techniques News
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
- Fluorescence Probe Paired with Engineered Enzymes Lights Up Tumors for Easier Surgical Removal
- Novel Hydrogel Could Become Bone Implant of the Future
- Skull Implant Design Could Shape Surgical Outcomes
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







